SCHEMBL8886501

SCHEMBL8886501

CC(=O)Nc1ccccc1NC(=NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 2/20 0.40
LMNA P02545 2/20 0.40
POLB P06746 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
MAPK1 P28482 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
CYP2C19 P33261 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
BRD9 Q9H8M2 1/20 0.36
GAA P10253 1/20 0.36
BRD4 O60885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29931186 0.87 GAA (0.41) HTTLMNAPOLBHPGDMAPK1
SCHEMBL20315227 0.86 RAB9A (0.45) HTTSMN1; SMN2LMNAPOLBALDH1A1
SCHEMBL5339653 0.83 LMNA (0.39) HTTLMNAPOLBMEN1KMT2A
SCHEMBL3785111 0.82 CTSK (0.41) LMNAALDH1A1MEN1KMT2ANPC1
SCHEMBL3785113 0.82 CTSK (0.41) LMNAALDH1A1MEN1KMT2ANPC1
SCHEMBL13785635 0.82 CTSK (0.41) LMNAALDH1A1MEN1KMT2ANPC1
SCHEMBL6811831 0.79 SMN1; SMN2 (0.51) HTTSMN1; SMN2TSHRLMNAPOLB
SCHEMBL10092627 0.78 CYP17A1 (0.48) HTTSMN1; SMN2BRD4
SCHEMBL14155353 0.78 CYP17A1 (0.48) HTTSMN1; SMN2BRD4
SCHEMBL17902833 0.77 ALDH1A1 (0.47) SMN1; SMN2TSHRLMNAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5602277-A Substituted benzene derivatives useful as neuraminidase inhibitors BIOCRYST PHARMACEUTICALS, INC. (US) 1997-02-11 US disclosed
WO-1996030329-A1 SUBSTITUTED BENZENE DERIVATIVES USEFUL AS NEURAMINIDASE INHIBITORS BIOCRYST PHARMACEUTICALS, INCORPORATED (US) 1996-10-03 WO disclosed